Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.840
-0.020 (-1.07%)
Nov 21, 2024, 3:09 PM EST - Market open
Milestone Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | - | -59.69 | -58.39 | -42.85 | -49.97 | -55.23 | |
| Depreciation & Amortization | - | 0.6 | 0.48 | 0.36 | 0.38 | 0.24 | |
| Other Amortization | - | 0.24 | - | - | - | - | |
| Loss (Gain) From Sale of Assets | - | - | 0.14 | - | - | - | |
| Loss (Gain) From Sale of Investments | - | -0.16 | -0.1 | - | - | - | |
| Stock-Based Compensation | - | 9.53 | 9.05 | 7.28 | 4.95 | 1.19 | |
| Other Operating Activities | - | 1.8 | -0.39 | -0.27 | -0.28 | -0.2 | |
| Change in Accounts Receivable | - | -2.33 | -0.76 | 0.1 | 0.04 | 0.12 | |
| Change in Accounts Payable | - | 1.04 | -0.91 | 0.64 | -2.08 | 3.52 | |
| Change in Income Taxes | - | - | - | - | - | -0.06 | |
| Change in Other Net Operating Assets | - | 2.53 | -1.6 | 1.52 | -3.76 | -0.74 | |
| Operating Cash Flow | - | -46.42 | -52.47 | -33.22 | -50.73 | -51.15 | |
| Capital Expenditures | - | -0.11 | -0.27 | - | - | -0.41 | |
| Investment in Securities | - | 4.87 | -56.85 | 70 | -70 | 0.03 | |
| Investing Cash Flow | - | 4.76 | -57.12 | 70 | -70 | -0.38 | |
| Long-Term Debt Issued | - | 50 | - | - | - | - | |
| Net Debt Issued (Repaid) | - | 50 | - | - | - | - | |
| Issuance of Common Stock | - | 0.58 | 3.09 | 0.12 | 25.22 | 85.41 | |
| Other Financing Activities | - | -2.79 | - | 4.93 | 48.01 | - | |
| Financing Cash Flow | - | 47.79 | 3.09 | 5.06 | 73.22 | 85.41 | |
| Net Cash Flow | - | 6.12 | -106.51 | 41.83 | -47.51 | 33.87 | |
| Free Cash Flow | - | -46.54 | -52.74 | -33.22 | -50.73 | -51.57 | |
| Free Cash Flow Margin | - | -4653.60% | -1054.82% | -221.49% | - | - | |
| Free Cash Flow Per Share | - | -1.08 | -1.24 | -0.79 | -1.73 | -3.27 | |
| Levered Free Cash Flow | - | -28.29 | -31.36 | -17.05 | -32.15 | -32.3 | |
| Unlevered Free Cash Flow | - | -26.94 | -31.36 | -17.05 | -32.15 | -32.3 | |
| Change in Net Working Capital | -1.57 | -1.23 | 3.34 | -2.23 | 5.78 | -2.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.